Navigation Links
Gene Therapy Used In Treating Cancer

A team of US researchers have successfully cured advanced melanoma skin cancer by manipulating the genes of white blood cells causing them to attack the cancer cells. //

A team of researchers the US National Cancer Institute (NCI) have confirmed in their research that are published in the journal Science that advanced melanoma, which is considered as the most deadly type of skin cancer can be continuously reduced by genetically engineering the patients own white blood cells (WBC) in recognising and attacking the cancer cells.

The researchers explained that they had successfully undertook this line of treatment for two patients, who were expected to live for up to six months only, and that the patients are now are cancer-free even after 18 months of the treatment. Dr Elias A. Zerhouni, director of the US National Institutes of Health, said, 'These results represent the first time gene therapy has been used successfully to treat cancer. Moreover, we hope it will be applicable not only to melanoma, but also for a broad range of common cancers, such as breast and lung cancer.'

The researchers explained that the WBC's of the body, or the lymphocytes, had been in the past used for treating certain types of skin cancer. They explained to have tried out the method on 17 patients in three different groups, by injecting into them the patients own lymphocytes that had been altered by the genetic introduction of T cell receptors, which guide the cells to find and destroy cancer tumour cells.

Stating that unfortunately these methods had failed to stall the disease in the first three groups, the researchers explained that they then tried to modify the treatment by injecting the genetically manipulated lymphocytes into the patients when the cells were at their most active growth phase. They explained that they then found that this generated better results.

They further stated that of the remaining 14 patients, in 2 of them the cancer had retreated and they have been disease free for almost a year. And that in the remaining two groups the patients continued to have significantly high levels of cancer-fighting cells even after a month of receiving the gene therapy. Elias Zerhouni said, 'We hope is will be applicable not only to melanoma, but also for a broad range of common cancers, such as breast and lung cancer.'
VIK
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2016)... , ... May 28, 2016 , ... After a year and a half of planning ... an extraordinary event. The Multiple Pathways of Recovery Conference was held May 2 -4, ... country and the United Kingdom came together to explore the many pathways individuals use to ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ... that it has been recognized as one of the best small businesses for new ... as one of nine small businesses providing progressive benefits to new parents on the ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team of ... food industries. Aside from its GMP accreditation, Validation Center is also a registered ... products, services and staff. , Validation Center is ISO17025 accredited and only offers ...
(Date:5/26/2016)... ... 26, 2016 , ... Intalere, the healthcare industry leader in ... inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., May 17-20, ... America’s healthcare providers. , The conference was highlighted by the announcement of the ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: